Investigator-Sponsored Protocol - Continued Use of Ibalizumab

Trial Profile

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

Phase of Trial: Phase II

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Ibalizumab (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 04 Jun 2015 According to the record, planned end date changed from 1 Nov 2015 to 1 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top